This year, company taking meetings via the Bio Partnering platform during the week of the JP Morgan Healthcare Conference, but will also take part in meetings with foreign investors.<\/p>\n
Maciej Wieczorek, CEO of Celon Pharma: We have an intensive week of meetings and presentations ahead of us. This year, we use our presence at JP Morgan to achieve two important goals: continuation of partnering talks in the field of our innovative projects, but also, we respond to the growing interest of foreign investors with whom we intend to meet and present our activities in selected segments<\/em>.<\/p>\n The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.<\/p>\n\n\n <\/p>\n","protected":false},"excerpt":{"rendered":"